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•  Using [3H]ryanodine binding assays, we determined the effect of CPVT and IVT 
associated CaM mutants on CaM’s modulation of RyR1 and RyR2 from native 
SR membranes that were isolated from porcine skeletal and cardiac muscle, 
respectively.  
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Fig. 5: Data of the functional effect of CPVT-associated CaM 
mutants on skeletal RyR1 modulation. When bound to low 
concentrations of Ca2+, wild type CaM (in its apo-state (Fig.4)) will 
activate the RyR1, activating Ca2+  release. Wild type CaM in its 
Ca2+-bound state (Fig.3) inhibits the RyR1, preventing Ca2+  leak. 
Shown in Figure 3, the mutations D132E and Q136P act quite 
similar to Apo-CaM, likely due to decreased Ca2+ sensitivity (lower 
Ca2+ binding affinity).   
Fig. 6: Data of the functional effect of CPVT-associated CaM 
mutants on cardiac RyR2 modulation. In both high and low Ca2+ 
concentrations, the wild type CaM will inhibit activity of the 
RyR2, allowing no Ca2+ flow. Shown in Figure 6, the mutations 
N54I and F90L act quite similar to the control (0nM CaM), and 
are shown to abolish modulation of the RyR2.  
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Calmodulin (CaM) is a 148 residue protein, with 
four Ca2+ binding domains (EF-hands): two high 
affinity Ca2+ binding sites in the C-lobe and two EF-
hand like domains in the N-lobe (shown in Figure 
1). Functional studies have shown that both the 
Apo and Ca-bound states of CaM modulates the 
activity of the SR Ca2+ release channel, known as 
the ryanodine receptor.  This ligand-gated channel 
is responsible for release of Ca2+ from the SR in 
response to an action potential, a process known 
as  Excitation-Contraction coupling (E-C coupling) 
in striated muscle. Mammalian tissues express 
three different RyR isoforms: RyR1, RyR2 and 
RyR3. Notably, skeletal muscle and cardiac muscle 
predominately expresses RyR1 and RyR2, 
respectively. 1  
 
The focus of this project was on CaM’s modulation 
of RyR1 and RyR2 activity. With 0.1 µM Ca2+, CaM 
(in its Apo state) has been shown to increase RyR1 
activity. However, with more than 1 µM Ca2+, CaM 
(in its Ca-bound state) decreases RyR1 activity. 
The modulation of RyR2 activity is different from 
that of RyR1, in that CaM decreases RyR2 activity 
at both high and low Ca2+ concentrations.  
Fig. 1: The structure of CaM 
with four Ca-binding 
domains: two on the C-lobe 
and two on the N-lobe. 
Mutations being studied can 
be found located at different 
places on the protein.   
N54I has is thought to cause CPVT by directly increasing RyR2 activity at diastolic 
cytoplasmic Ca levels (0.03-0.1 µM). 3 
 
F90L, associated with Idiopathic Ventricular Fibrillation, is suggested to be 
important for high-affinity cooperative calcium binding.4 
 
N98S, associated with CPVT, has been shown to decrease Ca affinity and abolish 
the CaM-mediated inhibition of RyR2 activity at diastolic cytoplasmic Ca levels 
(0.03-0.1 µM). 3 
 
A104V, associated with Ventricular Tachycardia, has also been shown to decrease 
Ca affinity. However, this mutation did not change the affinity of CaM binding to 
RyR2.5 
 
D132E and Q136P, both CPVT-associated CaM mutants, have been shown to 
impair Ca sensitivity of the C-lobe.2 
 
CPVT-Associated Mutants 
 
Catecholaminergic polymorphic ventricular tachycardia (CPVT) represents a 
treatable cause of sudden cardiac death in young adults and children. Mutations 
in CaM have been associated with severe forms of CPVT, with life-threatening 
arrhythmias occurring in these adolescents.2 Six mutations (A104V, N54I, F90L, 
N98S, D132E, and Q136P) are believed to affect the Ca-binding affinity of CaM, 
therefore affecting the modulation of the RyR2 which is essential in E-C coupling. 
By studying the functional effects of CPVT-associated CaM mutants on RyR1 and 
RyR2 modulation, we can begin to determine how these mutants are associated 
with CPVT and their mechanism of action.  
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SR Prep and [3H]ryanodine Binding Assay 
Pig skeletal SR vesicles were stripped of endogenous CaM by 30 min incubation 
with myosin light chain CaM binding peptide at 37ºC and sedimented by two 
centrifugation steps. The SR was incubated with subsaturating (100 nM) and 
saturating (800 nM) wt CaM or CaM mutants for 3 h at 37ºC with 15nM 
[3H]ryanodine and either 30nM or 30µM Ca2+. Unbound [3H]ryanodine was removed 
by filtration. Cardiac SR vesicles were assayed using the same conditions as 
[3H]ryanodine binding assay detailed above.  
 
 
lysis filter 
supernatant 
filter 
CaM glycerol stocks were used to inoculate an overnight starter culture of 250mL 
Luria Broth (100ug/mL Ampicillin). This was grown up for over 12 hours at 30ºC 
shaking at 225rpm. For each construct, 245mL of starter culture was distributed to a 
4L flask containing 0.85L of LB (50ug/mL Ampicillin), starter OD600 was 0.1. Bacteria 
were grown up for 2 hours at 37ºC shaking at 225rpm until OD600 was between 
0.8-1.0. 440uL of 1M IPTG was added to induce expression, and the cells were 
further incubated at 37ºC shaking at 225rpm for 4 hours. Cells were spun down at 
6000xg for 15 min in a SLA-3000 rotor at 4ºC using the RC-5B centrifuge. 
Supernatant was discarded and the pellet was resuspended in 20mM TRIS buffer. 
Cells were frozen overnight at -80oC. 
The pelleted cell debris was resuspended in 40mLs of homogenization buffer. On 
ice, the pellet was homogenized using a Bradson Sonicator for five 30s bursts.The 
cell debris was spun down at 9200 rpm in a SS34 rotor for 30 min at 4ºC. The 
supernatant was collected and 50uL was set aside for gel electrophoresis. The 
pelleted cell debris was discarded. 10mM CaCl2 was added to the cell lysate to 
promote CaM to be in a Ca-bound, open conformation, which exposes hydrophobic 
residues. The cell lysate was run over a column that contained 20mL of Phenyl 
Sepharose. CaM’s hydrophobic residues bound to the column, and other proteins 
were filtered through. Wash buffers were used to wash away any unbound non-
specifically bound proteins. Finally, CaM was eluted by running buffer which 
contains a Ca2+ chelator, EGTA, over the column. This causes CaM to return to a 
closed conformation, effectively breaking the hydrophobic interaction with the 
sepharose. After confirming that the elutes contained CaM by gel electrophoresis 
(Fig. 2), the elutes were dialyzed overnight in 4L of dialysis buffer II for 8 hours at 
4ºC. Protein concentration was determined by absorbance at 280 and by BCA 
assay methods. 
 
 
Fig. 2: Gel electrophoresis. Elutes with highest A280 were run 
on the gel to determine fractions that contained protein. 
30nM Ca 30µM Ca 
[3
H
]R
y 
bi
nd
in
g 
to
 H
SR
 (r
el
 to
 c
on
tr
ol
) 
100nM CaM 100nM CaM 800nM CaM 800nM CaM 
30nM Ca 30µM Ca 
100nM CaM 800nM CaM 100nM CaM 800nM CaM 
[3
H
]R
y 
bi
nd
in
g 
to
 H
SR
 (r
el
 to
 c
on
tr
ol
) 
Control  
(0nM CaM) 
Control  
(0nM 
CaM) 
Functional effect of CPVT-associated mutants on [3H]ryanodine 
binding to skeletal SR 
Functional effect of CPVT-associated mutants on [3H]ryanodine 
binding to cardiac SR 
Future Directions: 
Fig. 3: Calmodulin in its 
Apo-state (Ca-free state). 
CPVT and IVT mutations 
are highlighted in cyan.  
Fig. 4: Calmodulin in its 
Calcium-bound state. 
CPVT and IVT mutations 
are highlighted in cyan.  
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Site-directed Mutagenesis 
1uL of each mutated CaM plasmid was added to 45uL of Life technologies 
BL21(DE3)pLysS competent cells. The cells were then incubated on ice for 30 min. 
The bacteria was heat shocked by submerging the tubes in a 42ºC water bath for 
45 seconds and returning the tube back to ice for 2 minutes. 200uL of SOC was 
added and the cells were incubated for 60 min at 37ºC and shaken at 225rpm.The 
bacteria was then spread on Ampicillin plates and incubated overnight at 37ºC. 
 
Bacteria Grow Up and Protein Expression 
Protein Purification 
The Functional Effect of CPVT-associated mutants on Skeletal 
RyR1: 
•  A novel aspect of this project was the study of the CPVT-
associated mutants and their functional effect on skeletal RyR1. 
•  Q136P strongly activated RyR1 at all Ca2+ concentrations. D132E 
acted more like the wild type than Q136P, however, this mutation 
increases RyR1 activation. As shown in previous studies with 
RyR2, mutations D132E and Q136P impaired Ca2+ sensitivity of 
the C-lobe, which could be a potential cause of the high activation 
of the RyR1.  
•  At only high Ca2+ concentrations, N54I, F90L, and N98S caused 
increased activity of RyR1 compared to wild type. At low Ca2+ 
concentrations, A104V was a strong activator. 
 
The Functional Effect of CPVT-associated mutants on Cardiac 
RyR2: 
•  At high and low concentrations of Ca2+, CaM inhibits activity of 
the RyR2.  
•  Consistent with previous publications, N54I and F90L abolished 
the CaM-mediated inhibition of RyR2 activity, which is evidenced 
by their similarity to the control (0nM CaM) in these experiments.  
•  At low Ca2+ concentrations, A104V and Q136P were strong 
activators of RyR2; however, at low Ca2+ concentrations, A104V 
was a strong inhibitor of RyR2. 
•  Q136P was a modest activator of RyR2 at all Ca2+ 
concentrations, and at all Ca2+ concentrations, N98S and D132E 
were similar to the wild type.  
 This study adds a great deal to our understanding of these mutants’ affect on RyR function, but given the complexity of the results these 
CPVT and IVT mutants should be studied further to elucidate how single point mutations in CaM contribute to these devastating disorders. 
